TRUfill®'s Line in Intracranial aNeurysm Embolisation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

171 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-12-01

Study Completion Date

2014-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the long term efficacy and safety of the CODMAN TRUFILL®'s line of coils in the treatment of patients with intracranial ruptured or non-ruptured aneurysms in real-life routine clinical practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial Aneurysms

NCT02415010

Intracranial Aneurysm

TERMINATED

Neuroform Atlas Stent for Intracranial Aneurysm Treatment

NCT02783339

Intracranial Aneurysm

COMPLETED

Trenza Embolization Device for Intrasaccular Aneurysm Treatment

NCT04380350

Aneurysm Intracranial Aneurysm

ACTIVE_NOT_RECRUITING

Cascade Clinical Data Collection Protocol

NCT04760925

Intracranial Aneurysm

COMPLETED

Safety and Efficacy of Neuroform3TM for Intracranial Aneurysm Treatment

NCT00928265

Intracranial Aneurysm

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneurysms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TRUFILL® DCS Orbit Galaxy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient ≥ 18 years old
* Patient presenting one or more ruptured or non-ruptured intracranial aneurysms assessed by angiography
* Patient implanted with one or more CODMAN TRUFILL® coils
* Patient agree to take part in the study, or agreement of a representative of the patient in case of patient inability, after being informed by the investigator and have received information letter.

Exclusion Criteria

* Patient who does not accept to take part in the study after being informed
* Patient already enrolled in a clinical trial involving experimental medication or device.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No